K-Run Ventures
Overview
K-Run Ventures is a venture capital firm based in Seoul, South Korea that invests in the bio, healthcare, and technology sectors.
Portfolio Companies
12
Website
krunventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pin Therapeutics | Aug 2019 | Series A | Co-investor |
| PuzzleAI | May 2022 | Series B | Co-investor |
| A-TEAM VENTURES | Sep 2019 | Series A | Co-investor |
| READi Robust Machine | Aug 2026 | Series B | Co-investor |
| TerraLIX | Apr 2022 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is K-Run Ventures based?
K-Run Ventures is headquartered in Seoul, South Korea.
When was K-Run Ventures founded?
Founding year information for K-Run Ventures is not publicly available.
How many portfolio companies does K-Run Ventures have?
K-Run Ventures has 12 portfolio companies in Caplight's dataset.
What are some companies in K-Run Ventures's portfolio?
Portfolio companies visible on Caplight include Pin Therapeutics, PuzzleAI, A-TEAM VENTURES, READi Robust Machine, TerraLIX.
What was K-Run Ventures's most recent investment shown here?
K-Run Ventures's most recent investment in this portfolio sample was in READi Robust Machine in 2026.
What sectors does K-Run Ventures focus on?
K-Run Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce, Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, FinTech.
What company stages does K-Run Ventures focus on?
K-Run Ventures typically invests at the Early stage.
What is K-Run Ventures's AUM?
K-Run Ventures's assets under management are estimated between $140.1M and $140.1M.